Medical Balloon Catheter Market: Size, Share, and Growth Outlook to 2035

The Medical Balloon Catheter Market is experiencing significant growth, driven by the increasing prevalence of cardiovascular diseases, rising demand for minimally invasive procedures, and technological advancements in catheter technology. According to detailed industry evaluation, the market was valued at USD 5.3 billion in 2025 and is projected to reach USD 9.2 billion by 2035, exhibiting a CAGR of 5.7% during the forecast period 2026-2035. Inflatable balloon catheters, non-inflatable balloon catheters, and specialty balloon catheters remain among the most sought-after products globally due to their critical role in angioplasty, urological procedures, gastrointestinal procedures, and cardiac procedures. Furthermore, the growing geriatric population and expanding healthcare infrastructure in emerging markets are broadening the adoption base across hospitals, ambulatory surgical centers, and specialty clinics.

By application, angioplasty dominates the segment, valued at USD 2,100 million in 2024 and expected to reach USD 3,600 million by 2035, illustrating its essential role in addressing cardiovascular diseases. The growth in this area is driven by an increase in the prevalence of coronary artery disease and the rising number of angioplasty surgeries performed globally. Urological procedures are experiencing steady expansion, propelled by the growing incidences of urological disorders and an aging population. By material, polyurethane and nitinol are anticipated to experience significant growth due to their enhanced flexibility and durability. Recent developments include Boston Scientific announcing the acquisition of Vascular Concepts Ltd to bolster its peripheral vascular catheter portfolio, Terumo Corporation announcing a strategic partnership with Abbott Laboratories to co-develop and co-commercialize next-generation drug-coated balloon technologies, and Medtronic launching a new drug-coated balloon catheter designed for complex below-the-knee lesions.

North America holds the majority valuation of USD 2,300 million in 2024, projected to reach USD 3,600 million by 2035, attributed to advanced healthcare infrastructure and high demand for minimally invasive surgical procedures. Europe follows with strong growth trends, fueled by an increase in cardiovascular diseases and technological advancements in medical devices. The Asia-Pacific region shows moderate increase driven by rising healthcare expenditure and growing awareness regarding advanced treatment options. The competitive landscape features key players including Boston Scientific, Vascular Concepts, Terumo Corporation, Cook Medical, Abbott Laboratories, Medtronic, Cordis Corporation, B. Braun Melsungen AG, Cardinal Health, Merit Medical Systems, Johnson & Johnson, Spectranetics, AngioDynamics, Avinger, NuMed, and Asahi Intecc.

FAQs

What is the current market size of the medical balloon catheter market?
The market was valued at USD 5.3 billion in 2025 and is projected to reach USD 9.2 billion by 2035, exhibiting a CAGR of 5.7%.

Which segment dominates the medical balloon catheter market?
Angioplasty holds the largest market share by application, while polyurethane leads by material. Inflatable balloon catheters dominate by type, and hospitals represent the largest end-use segment.

Who are the key players in the medical balloon catheter market?
Key players include Boston Scientific, Vascular Concepts, Terumo Corporation, Cook Medical, Abbott Laboratories, Medtronic, Cordis Corporation, B. Braun Melsungen AG, Cardinal Health, Merit Medical Systems, Johnson & Johnson, Spectranetics, AngioDynamics, Avinger, NuMed, and Asahi Intecc.

#MedicalBalloonCatheterMarket #MinimallyInvasiveSurgery #InterventionalCardiology #Angioplasty #MedicalDevices